Quarterly report · Q3
2590.TEDINET S100SE2I
Period2023-01-21 → 2023-10-20
Filed2023-12-01
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥165.3bn | 2023-01-21 → 2023-10-20 | Cons. | Net sales |
| Revenue | ¥160.1bn | 2022-01-21 → 2023-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥124.6bn | 2022-01-21 → 2022-10-20 | Cons. | Net sales |
| Operating income | ¥5.8bn | 2023-01-21 → 2023-10-20 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2022-01-21 → 2022-10-20 | Cons. | Operating income |
| Ordinary income | ¥5.2bn | 2023-01-21 → 2023-10-20 | Cons. | Ordinary income |
| Ordinary income | ¥591m | 2022-01-21 → 2023-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2022-01-21 → 2022-10-20 | Cons. | Ordinary income |
| Profit before tax | ¥7.7bn | 2023-01-21 → 2023-10-20 | Cons. | Income before income taxes |
| Profit before tax | ¥2.9bn | 2022-01-21 → 2022-10-20 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.2bn | 2023-01-21 → 2023-10-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥507m | 2022-01-21 → 2023-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥736m | 2022-01-21 → 2022-10-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.5bn | 2023-01-21 → 2023-10-20 | Cons. | Profit loss |
| Net income | ¥725m | 2022-01-21 → 2022-10-20 | Cons. | Profit loss |
| Total assets | ¥185.6bn | at 2023-10-20 | Cons. | Assets |
| Total assets | ¥164.2bn | at 2023-01-20 | Cons. | Assets |
| Total assets | ¥167.8bn | at 2022-10-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥95.1bn | at 2023-10-20 | Cons. | Liabilities |
| Total liabilities | ¥80.1bn | at 2023-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥90.5bn | at 2023-10-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-01-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2022-10-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥32.8bn | at 2023-10-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.2bn | at 2023-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥266.09 | 2023-01-21 → 2023-10-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.78 | 2023-07-21 → 2023-10-20d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.4 | 2022-01-21 → 2023-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.99 | 2022-01-21 → 2022-10-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.45 | 2022-07-21 → 2022-10-20d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.7% | at 2023-10-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.9% | at 2022-10-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-10-20 | −¥313m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-10-20 | −¥313m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-10-20 | −¥1.1bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-10-20 | ¥118.0bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-10-20 | ¥117.9bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-10-20 | ¥26m |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-10-20 | ¥4.8bn |
| jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-10-20 | −¥406m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-10-20 | ¥17.1bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-10-20 | ¥17.1bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-10-20 | ¥6m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-10-20 | ¥1.4bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-10-20 | ¥20.6bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-10-20 | ¥20.6bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-10-20 | ¥694m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-10-20 | ¥9.9bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-10-20 | ¥9.7bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-10-20 | ¥280m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-10-20 | ¥397m |
| —segment total | revenue | 2023-01-21 → 2023-10-20 | ¥165.6bn |
| —segment total | revenue external | 2023-01-21 → 2023-10-20 | ¥165.3bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-10-20 | ¥313m |
| —segment total | segment profit | 2023-01-21 → 2023-10-20 | ¥6.8bn |
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-10-20 | −¥521m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-10-20 | −¥521m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-10-20 | −¥1.0bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥83.6bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥83.5bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥24m |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | ¥2.8bn |
| jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-10-20 | −¥380m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥16.4bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥16.4bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥6m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | ¥1.3bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥15.5bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥15.5bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | −¥752m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥9.7bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥9.2bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥490m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | ¥377m |
| —segment total | revenue | 2022-01-21 → 2022-10-20 | ¥125.2bn |
| —segment total | revenue external | 2022-01-21 → 2022-10-20 | ¥124.6bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥521m |
| —segment total | segment profit | 2022-01-21 → 2022-10-20 | ¥3.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 397
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 490000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 521000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -521000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 83554000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 15507000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 9654000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 16445000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 125161000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -521000000 | JPY |
| Net sales | Prior1YTDDuration | 124640000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 2767000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -752000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 377000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 1316000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | -380000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 3329000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -1002000000 | JPY |
| Operating income | Prior1YTDDuration | 2326000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 117930000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 20628000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 9664000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 17054000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 165278000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 165278000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 26000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 280000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 313000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -313000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 117957000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 20628000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 9944000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 17060000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 165591000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -313000000 | JPY |
| Net sales | CurrentYTDDuration | 165278000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 4788000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 694000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 397000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |